Paul M Lundy Selected Research

Muscarinic Antagonists

1/2006

Development of the bisquaternary oxime HI-6 toward clinical use in the treatment of organophosphate nerve agent poisoning.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul M Lundy Research Topics

Disease

4	Poisoning 07/2011 - 11/2004
1	Airway Obstruction (Choking) 04/2007
1	Apnea 11/2004

Drug/Important Bio-Agent (IBA)

3	asoxime chloride (H16)IBA 07/2011 - 03/2005
3	Nerve AgentsIBA 07/2011 - 01/2006
2	SaltsIBA 07/2011 - 03/2005
2	OximesIBA 07/2011 - 01/2006
1	pralidoxime (Protopam Chloride)FDA Link 07/2011
1	Obidoxime Chloride (Obidoxime)IBA 07/2011
1	N,N'- monomethylenebis(pyridiniumaldoxime)IBA 07/2011
1	InsecticidesIBA 07/2011
1	Irritants (Vesicants)IBA 04/2007
1	Muscarinic AntagonistsIBA 01/2006
1	AcetylcholinesteraseIBA 01/2006
1	Atropine FDA LinkGeneric 01/2006
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2006
1	OrganophosphatesIBA 01/2006
1	SomanIBA 03/2005
1	Chemical Warfare AgentsIBA 11/2004
1	Cholinergic Agents (Cholinergics)IBA 11/2004
1	VX (EDIM)IBA 11/2004